semaglutide polycystic ovary syndrome Alleviates Ovarian Oxidative Stress and Autophagy via the | DDDT Frontiers | The maintenance of

Additionally, the GLP-1 receptor agonist cardiovascular therapy market is expanding due to the growing acceptance of preventive treatment techniques and the growing awareness among healthcare professionals regarding cardiometabolic risk management

Some researchers also report effects on menstrual cycles and joint discomfort

Providers can then prescribe FDA-approved GLP-1 medications (like Wegovy) for weight loss

The Takeaway Obesity is linked to more active MS, and while weight loss hasnt been shown to reverse the disease, it may help reduce inflammation and make symptoms easier to manage

Limitations and Considerations The number of non-white participants was low, which may limit the generalizability of results

Zeng M, Yi S, Xiao Y, Chen Z